| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 68.163 | 15.771 | 9.467 | 78.230 | 166.513 | 208.261 | 283.657 | 226.006 | 28.918 |
| Total Income - EUR | 76 | 69.979 | 17.020 | 24.012 | 71.678 | 173.860 | 196.567 | 293.190 | 219.206 | 103.767 |
| Total Expenses - EUR | 5.283 | 41.982 | 35.892 | 58.686 | 87.148 | 185.115 | 200.215 | 255.911 | 242.137 | 134.693 |
| Gross Profit/Loss - EUR | -5.207 | 27.997 | -18.872 | -34.674 | -15.471 | -11.255 | -3.648 | 37.279 | -22.931 | -30.926 |
| Net Profit/Loss - EUR | -5.209 | 26.996 | -19.029 | -34.769 | -16.253 | -12.746 | -5.475 | 34.503 | -25.178 | -32.791 |
| Employees | 0 | 3 | 4 | 5 | 7 | 10 | 10 | 9 | 7 | 1 |
Check the financial reports for the company - Pavele Vibropresate S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 67.800 | 67.856 | 64.192 | 60.545 | 70.335 | 63.961 | 133.887 | 108.483 | 97.448 | 43.729 |
| Current Assets | 15.653 | 30.212 | 42.807 | 92.944 | 98.257 | 48.878 | 24.683 | 43.041 | 103.472 | 86.088 |
| Inventories | 363 | 12.510 | 24.975 | 65.466 | 79.807 | 36.869 | 15.077 | 25.812 | 63.187 | 65.638 |
| Receivables | 14.969 | 12.284 | 14.811 | 27.421 | 18.407 | 6.927 | 7.253 | 17.063 | 33.317 | 18.573 |
| Cash | 321 | 5.418 | 3.021 | 56 | 43 | 5.081 | 2.353 | 166 | 6.969 | 1.878 |
| Shareholders Funds | -10.202 | 16.898 | -2.417 | -37.142 | -52.633 | -64.381 | -68.429 | -34.179 | -59.253 | -91.713 |
| Social Capital | 45 | 45 | 44 | 43 | 84 | 83 | 81 | 41 | 40 | 40 |
| Debts | 93.655 | 81.170 | 109.416 | 190.630 | 221.226 | 177.219 | 226.999 | 185.703 | 260.174 | 221.530 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2361 - 2361" | |||||||||
| CAEN Financial Year |
2361
|
|||||||||
Comments - Pavele Vibropresate S.r.l.